Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Sotac Pharmaceuticals IPO is a book build issue of ₹33.30 crores. The issue is entirely a fresh issue of 0.30 crore shares of ₹33.30 crore.
Sotac Pharmaceuticals IPO bidding started from Mar 29, 2023 and ended on Apr 3, 2023. The allotment for Sotac Pharmaceuticals IPO was finalized on Apr 10, 2023. The shares got listed on NSE SME on Apr 13, 2023.
Sotac Pharmaceuticals IPO price band is set at ₹111.00 per share . The lot size for an application is 1,200. The minimum amount of investment required by an retail is ₹1,26,000 (1200 shares). The minimum lot size investment for HNI is 2 lots (2,400 shares), amounting to ₹2,66,400.
Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The market maker of the company is Sunflower Broking Pvt.Ltd..
Refer to Sotac Pharmaceuticals IPO RHP for detailed Information.
| IPO Date | March 29, 2023 to April 3, 2023 |
| Listing Date | April 13, 2023 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹105 to ₹111 per share |
| Issue Price Final | ₹111 per share |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 30,00,000 shares (aggregating up to ₹33.30 Cr) |
| Reserved for Market Maker | 1,50,000 shares Sunflower Broking Pvt.Ltd. (aggregating up to ₹1.67 Cr) |
| Net Offered to Public | 28,50,000 shares (aggregating up to ₹31.64 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 80,50,000 shares |
| Share Holding Post Issue | 1,10,50,000 shares |
Sotac Pharmaceuticals IPO offers total 30,00,000 shares. Out of which 14,23,200 (47.44%) allocated to QIB, 5,70,000 (19.00%) allocated to QIB, 4,28,400 (14.28%) allocated to NII, 9,98,400 (33.28%) allocated to RII and 8,53,200 (28.44%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 1,50,000 (5.00%) |
| QIB Shares Offered | 14,23,200 (47.44%) |
| − Anchor Investor Shares Offered | 8,53,200 (28.44%) |
| − QIB (Ex. Anchor) Shares Offered | 5,70,000 (19.00%) |
| NII (HNI) Shares Offered | 4,28,400 (14.28%) |
| Retail Shares Offered | 9,98,400 (33.28%) |
| Total Shares Offered | 30,00,000 (100.00%) |
Sotac Pharmaceuticals IPO raises ₹9.47 crore from anchor investors. Sotac Pharmaceuticals IPO Anchor bid date is March 28, 2023. Sotac Pharmaceuticals IPO Anchor Investors list
| Bid Date | March 28, 2023 |
| Shares Offered | 8,53,200 |
| Anchor Portion Size (In Cr.) | 9.47 |
| Anchor lock-in period end date for 50% shares (30 Days) | May 10, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | July 9, 2023 |
Sotac Pharmaceuticals IPO opens on March 29, 2023, and closes on April 3, 2023.
| IPO Open Date | Wed, Mar 29, 2023 |
| IPO Close Date | Mon, Apr 3, 2023 |
| Tentative Allotment | Mon, Apr 10, 2023 |
| Initiation of Refunds | Tue, Apr 11, 2023 |
| Credit of Shares to Demat | Wed, Apr 12, 2023 |
| Tentative Listing Date | Thu, Apr 13, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Mon, Apr 3, 2023 |
Investors can bid for a minimum of 1,200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,33,200 |
| Retail (Max) | 1 | 1,200 | ₹1,33,200 |
| HNI (Min) | 2 | 2,400 | ₹2,66,400 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.
SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.
Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.
With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-20 | 3,038.21 | 2,882.64 | 8.75 | 305.73 | 75.73 | 15.13 |
| 31-Mar-21 | 3,469.75 | 4,894.97 | -236.54 | 249.36 | 19.36 | 1,035.80 |
| 31-Mar-22 | 3,525.35 | 7,337.02 | 287.86 | 662.19 | 432.19 | 1,134.59 |
| 30-Sep-22 | 6,461.60 | 3,994.65 | 46.55 | 797.41 | 567.41 | 2,185.52 |
| Amount in ₹ Lakhs | ||||||
The market capitalization of Sotac Pharmaceuticals IPO is ₹122.66 Cr.
| KPI | Values |
|---|---|
| ROE | 6.38% |
| ROCE | 19.03% |
| Debt/Equity | 2.74 |
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 132.14 |
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
[Dilip Davda] This pharma/healthcare segment company has marked wild fluctuations in its bottom lines for the reported periods. Based on FY23 annualized earnings, the issue appears exorbitantly priced. It is operating in a highly competitive and fragmented segment. SPL’s debt level is also higher and raises concerns. There is no harm in skipping this pricey bet. Read detail review...
| Listing Date | April 13, 2023 |
| BSE Script Code | |
| NSE Symbol | SOTAC |
| ISIN | INE0O2D01012 |
| Final Issue Price | ₹111 per share |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹111.00 |
| Open | ₹115.00 |
| Low | ₹115.00 |
| High | ₹120.75 |
| Last Trade | ₹120.75 |
Sotac Pharmaceuticals Ltd.
Plot No. PF-21, Nr. ACME Pharma,
Opp. Teva Pharma Sanand GIDC-II,
Sanand,
Ahmedabad, Gujarat, 382110
Phone: +91 90819 93300
Email: compliance@sotacpharma.com
Website: http://www.sotacpharma.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: sotac.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Sotac Pharmaceuticals IPO is a SME IPO of 30,00,000 equity shares of the face value of ₹10 aggregating up to ₹33.30 Crores. The issue is priced at ₹111 per share. The minimum order quantity is 1200.
The IPO opens on March 29, 2023, and closes on April 3, 2023.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sotac Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Sotac Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sotac Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sotac Pharmaceuticals IPO opens on March 29, 2023 and closes on April 3, 2023.
Sotac Pharmaceuticals IPO lot size is 1200, and the minimum amount required for application is ₹1,33,200.
You can apply in Sotac Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Sotac Pharmaceuticals IPO will be done on Monday, April 10, 2023, and the allotted shares will be credited to your demat account by Wednesday, April 12, 2023. Check the Sotac Pharmaceuticals IPO allotment status.
The Sotac Pharmaceuticals IPO listing date is on Thursday, April 13, 2023.
Useful Articles
RHP